• Earlier this month, AeroVironment, Inc. announced that Italy’s Directorate of Aeronautical Armaments and Airworthiness granted the MQ-31A military designation to its JUMP 20 unmanned aircraft system, confirming it as an official capability in the Italian Army and advancing an April 2025 contract to replace Italy’s legacy ISR fleet.
• This formal recognition strengthens JUMP 20’s role within NATO forces and highlights AeroVironment’s growing presence in European defense programs, supported by its runway-independent VTOL design, modular payload capacity, and established operational track record.
• Next, we’ll examine how JUMP 20’s new MQ-31A status with Italy could influence AeroVironment’s investment narrative around international defense expansion.

Find 44 companies with promising cash flow potential yet trading below their fair value.

AeroVironment Investment Narrative Recap

To own AeroVironment, you need to believe it can convert its UAS and counter-UAS portfolio into durable, higher-margin growth while integrating BlueHalo and managing lumpier defense budgets. Italy’s MQ-31A designation for JUMP 20 supports the international diversification catalyst by reinforcing NATO adoption, but it does not fundamentally change the biggest near term risk, which remains AeroVironment’s heavy exposure to U.S. contracts and its still-pressured margin profile after recent impairments.

Among recent news, Germany’s US$30.9 million LARUS order for the Puma family is especially relevant, because it underscores the same theme as Italy’s MQ-31A decision: AeroVironment is increasingly embedded in NATO-standard, interoperable systems. Together, these European wins tie directly into the key catalyst of expanding international defense programs and building a broader, multi-country backlog that can partially offset U.S. funding volatility and program timing risk.

Yet beneath these contract wins, investors should be aware that AeroVironment’s margin pressure and reliance on shifting defense budgets could still...

AeroVironment's narrative projects $2.9 billion revenue and $129.0 million earnings by 2029. This requires 13.4% yearly revenue growth and a $394.1 million earnings increase from -$265.1 million today.

Uncover how AeroVironment's forecasts yield a $251.93 fair value, a 76% upside to its current price.

Exploring Other Perspectives

While Italy’s MQ-31A news supports the international growth story, the most bearish analysts still expected only about US$2.9 billion revenue and US$239 million earnings by 2029, reminding you that views on contract concentration risk can differ widely and may shift again as new data comes in.

Explore 11 other fair value estimates on AeroVironment - why the stock might be worth over 3x more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your AeroVironment research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free AeroVironment research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate AeroVironment's overall financial health at a glance.

No Opportunity In AeroVironment?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.